Standout Papers

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung ... 2004 2026 2011 2018 1.9k
  1. Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy (2004)
    Nasser H. Hanna, Frances A. Shepherd et al. Journal of Clinical Oncology

Immediate Impact

10 by Nobel laureates 13 from Science/Nature 111 standout
Sub-graph 1 of 20

Citing Papers

Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
2022 Standout
Evaluating eligibility criteria of oncology trials using real-world data and AI
2021 StandoutNature
1 intermediate paper

Works of Shaharyar being referenced

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout

Author Peers

Author Last Decade Papers Cites
Shaharyar 1501 1667 102 343 5 2.0k
Klára Szondy 1541 1729 102 366 11 2.0k
Laurent Gressot 1495 1528 90 310 7 1.8k
H. Spiridonidis 1640 1730 93 531 6 2.1k
I. Melezínek 1362 1396 164 335 15 2.0k
Claude Denham 969 2497 188 346 10 3.0k
Sofia Paul 1798 1872 138 458 24 2.7k
Susan Coughlin 1481 1491 112 534 21 2.1k
Purvish Parikh 1737 2081 184 512 20 2.6k
Lauren Ambrogio 892 1119 53 839 6 1.9k
Ira A. Oliff 1256 1189 59 443 12 1.7k

All Works

Loading papers...

Rankless by CCL
2026